Last updated on March 2019

Effect of Medical Marijuana on Neurocognition and Escalation of Use


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Anxiety | Pain | Insomnia | Acute Pain Service | Endogenous depression | ANXIETY NEUROSIS | Depression
  • Age: Between 18 - 65 Years
  • Gender: Male or Female

Inclusion Criteria:

  1. Men and women aged 18-65 years, inclusive;
  2. Competent and willing to provide written informed consent;
  3. Desire to use medical marijuana for self-reported pain, sleep, or affective (mood and/or anxiety including PTSD) symptoms.
  4. Not in possession of a medical marijuana card, but expressing intent to get one.
  5. Able to communicate in English language.

Exclusion Criteria:

  1. Current daily marijuana use (prior to enrollment)
  2. Current substance use disorders (e.g. cocaine, opiate, stimulant). Light to moderate alcohol use is permitted (defined as 16 or less on the AUDIT), and nicotine dependence is permitted because of the high co-use of nicotine and marijuana. Participants cannot meet current SCID criteria for a use disorder on any illicit substance other than nicotine.
  3. Pregnant (verified by a urine test).
  4. In the opinion of the investigator, not able to safely participate in this study because of any medical or psychological issues (e.g. psychosis) that might compromise their safety.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.